S1P1 receptor modulators used as a disease-modifying treatment in multiple sclerosis increase invitromelanoma cell lines proliferation at a therapeutic doseR. Carvajal,C. Tur,X. Martinez-Gomez,J. Esperalba,M. Rodriguez, A. Cobo-Calvo P. Carbonell-Mirabent,J. Rio,J. Castillo-Justribo,A. Pappolla,N. Braga,N. Mongay, J. A. Rodrigo-Pendas,A. Vidal-Jordana,G. Arrambide, B. Borras-Bemejo,B. Rodriguez-Acevedo,A. Zabalza,L. Midaglia,I. Galan,M. Comabella,J. Sastre-Garriga,X. Montalban,M. Tintore,S. Otero-RomeroMULTIPLE SCLEROSIS JOURNAL(2022)引用 0|浏览21AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要